CHGB and Alzheimer disease: It is well known that the development and progression of AD is strongly correlated with ROS production and ROS-based neuronal injury.(1,31,32) It is possibility that changes in secretogranin-1 expression in neurites relates to these neurodegenerative disorders in some form.